ALDOB

ALDOB Full Name

aldolase B, fructose-bisphosphate

ALDOB Introduction

Aldolase B, Fructose-Bisphosphate (ALDOB) is a key enzyme belonging to the aldolase family, specialized in the cleavage of fructose-1,6-bisphosphate and fructose-1-phosphate into smaller sugar metabolites. It catalyzes critical reactions in fructose metabolism, playing an essential role in breaking down dietary fructose for energy production and glucose synthesis. This enzyme is primarily localized in the cytoplasm and is predominantly expressed in tissues involved in fructose processing, including the liver, small intestine, and kidney. ALDOB is recognized not only as a metabolic enzyme but also as a key regulator of carbohydrate homeostasis, with profound implications for metabolic health, fructose tolerance, and disease prevention.ALDOB serves as a critical mediator of fructose metabolism, targeting fructose-derived substrates to facilitate their breakdown and integration into central metabolic pathways. It cleaves fructose-1-phosphate into glyceraldehyde and dihydroxyacetone phosphate, which are then further metabolized to produce energy or synthesize glucose. Beyond fructose processing, ALDOB contributes to maintaining carbohydrate balance by ensuring efficient utilization of dietary fructose, preventing its accumulation and toxicity. Its activity also supports normal liver function, as the liver is the primary organ responsible for fructose metabolism and detoxification of excess fructose.

Figure 1.The structure of ALDOB.

Isoforms and Genetic Architecture

The human ALDOB gene is located on chromosome 9q31.2 and spans approximately 16 kb, containing 9 exons. A single major transcript encodes a 364-amino acid protein (approximately 39 kDa) that assembles into a homotetramer. Two other aldolase isoforms exist in humans: ALDOA (muscle type, chromosome 16q24.3, ubiquitously expressed) and ALDOC (brain type, chromosome 17q11.2, expressed in brain, smooth muscle, and adipocytes). ALDOA and ALDOC have much higher specificity for FBP over F1P (FBP/F1P activity ratio >50:1) compared to ALDOB (ratio ~3-5:1), which explains why only aldolase B deficiency produces fructose intolerance. The three isoforms share approximately 65-70% amino acid sequence identity but have distinct kinetic properties and tissue distributions. Aldolase B deficiency does NOT affect muscle glycolysis (ALDOA compensates) or brain metabolism (ALDOC compensates), explaining the tissue-specific phenotype.

Clinical Significance of ALDOB Dysregulation
Dysregulation of ALDOB is associated with fructose metabolism disorders and a range of pathological conditions. A common genetic mutation of ALDOB leads to hereditary fructose intolerance, an autosomal recessive disorder characterized by impaired fructose breakdown, resulting in the accumulation of fructose-1-phosphate in the liver and kidneys. This accumulation causes liver damage, hypoglycemia, and renal dysfunction, particularly in individuals consuming dietary fructose. Reduced ALDOB activity is also linked to metabolic syndrome, non-alcoholic fatty liver disease, and insulin resistance, as it disrupts carbohydrate homeostasis and energy metabolism. Additionally, ALDOB expression levels are considered a potential biomarker for assessing fructose metabolism capacity and disease risk, highlighting its clinical relevance in metabolic medicine and therapeutic development.

Alternate Names for ALDOB

ALDOB; aldolase B, fructose-bisphosphate; fructose-bisphosphate aldolase B; aldolase 2; liver-type aldolase; aldolase B, fructose-bisphosphatase; ALDB; ALDO2;